Micro Systems Engineering

Executive Summary

Micro Systems Engineering (MSEI) is a specialized contract development and manufacturing organization (CDMO) providing design, development, and high-volume production of Class III medical microelectronics and active implantable medical devices (AIMDs). Operating a vertically integrated 'digital factory' in Lake Forest, California, MSEI leverages advanced automation, microelectronics expertise, and end-to-end traceability to deliver life-sustaining implantable technologies with uncompromising quality and regulatory compliance. The company serves leading medical device OEMs, primarily in the cardiovascular space, and has built a reputation for reliability in a demanding market where product failure is not an option. MSEI is well-positioned to benefit from secular tailwinds, including the aging global population, rising prevalence of cardiac arrhythmias, and increasing adoption of implantable devices such as pacemakers, defibrillators, and neurostimulators. Its digital factory enables faster time-to-market and greater flexibility for OEMs, which is critical as device complexity increases. While MSEI is private and financial details are undisclosed, its focus on high-barrier-to-entry Class III devices provides a competitive moat. Growth will be driven by expanding existing partnerships, winning new programs, and potentially adding capacity. Key risks include customer concentration and reliance on FDA approvals for OEM products. Overall, MSEI appears well-positioned for steady growth in a niche but essential sector.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Digital Factory Capacity or New Automation Capabilities60% success
• Q2 2027New Long-Term Supply Agreement with a Major Cardiac Device OEM40% success
• Q3 2026FDA Approval of a Key Customer's Novel Implantable Device Produced by MSEI50% success